oxazoles has been researched along with panamesine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoszyk, GD; Dahmen, N; Fischer, V; Hiemke, C; Hödl, P; Reuss, S; Rujescu, D | 1 |
| Maj, J; Mazela, H; Rogóz, Z; Skuza, G | 1 |
| Frieboes, RM; Holsboer, F; Murck, H; Steiger, A; Wiedemann, K | 1 |
| Antonijevic, I; Frieboes, RM; Hinze-Selch, D; Kraus, T; Murck, H; Pollmächer, T; Steiger, A | 1 |
| Gotthardt, U; Huber, MT; Krieg, JC; Schreiber, W | 1 |
| Andreas, J; Benkert, O; Eissner, D; Gründer, G; Heydari, N; Müller, MJ; Nickel, O; Schlegel, S; Schlösser, R; Wetzel, H | 1 |
| Okuyama, S | 1 |
| Benkert, O; Gründer, G; Marx-Dannigkeit, P; Müller, MJ; Müller-Siecheneder, F; Wetzel, H | 1 |
1 review(s) available for oxazoles and panamesine
| Article | Year |
|---|---|
[Atypical antipsychotic profiles of sigma receptor ligands].
Topics: Animals; Anisoles; Antipsychotic Agents; Clinical Trials as Topic; Dopamine; Dopamine D2 Receptor Antagonists; Drug Evaluation, Preclinical; Humans; Ligands; Oxazoles; Piperazines; Piperidines; Propylamines; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Tartrates | 1999 |
4 trial(s) available for oxazoles and panamesine
| Article | Year |
|---|---|
Open clinical trial on the sigma ligand panamesine in patients with schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Female; Humans; Male; Oxazoles; Piperidines; Prolactin; Receptors, sigma; Schizophrenia; Sleep | 1997 |
Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antipsychotic Agents; Blood Cell Count; Double-Blind Method; Electroencephalography; Female; Humans; Locus Coeruleus; Male; Oxazoles; Piperidines; Receptors, sigma; Schizophrenia; Sleep; Tumor Necrosis Factor-alpha | 1999 |
Efficacy and safety of the sigma receptor ligand EMD 57445 (panamesine) in patients with schizophrenia: an open clinical trial.
Topics: Adult; Antipsychotic Agents; Female; Humans; Ligands; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, sigma; Schizophrenia; Schizophrenic Psychology | 1999 |
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Biotransformation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, sigma; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
3 other study(ies) available for oxazoles and panamesine
| Article | Year |
|---|---|
Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain.
Topics: Animals; Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Female; Hippocampus; In Situ Hybridization; Oxazoles; Piperidines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, sigma | 1996 |
Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity.
Topics: Animals; Antipsychotic Agents; Locomotion; Male; Mice; Morphine; Oxazoles; Piperidines; Rats; Rats, Wistar | 1996 |
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzamides; Blood-Brain Barrier; Corpus Striatum; Female; Humans; Male; Middle Aged; Oxazoles; Piperidines; Pyrimidines; Pyrrolidines; Receptors, Dopamine D2; Receptors, sigma; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1999 |